Board of Directors

The Board of Directors oversees the day-to-day running of our association and the Chair is the highest representative of AseBio. The assembly held in December 2021 chose the candidacy with Ana Polanco (Merck) as chairwoman and Belén Barreiro (Ingenasa), Elena Rivas (A4Cell) y Javier Terriente (Zeclinics) as the three vice-presidents. They will hold these offices until late 2023.

Imagen Ana Polanco - Presidenta de AseBio III

Merck

Chairwoman

Ana Polanco

Director of Market Access and Corporate Affairs at Merck since 2015. She is also a member of FEI (Forum of Innovative Companies), of the Board of Directors of the Digital Health Association and Dr. of the Executive Committee of CLOSINGAP.

Ingenasa

1st Vice President

Belén Barreiro

General Director at Ingenasa, a company specializing in biotechnology for the veterinary sector, where she began in 1994 as director of Marketing.

Arrays For Cell Nanodevices

2sd Vice President

Elena Rivas

CEO at Arrays for Cell Nanodevices, SL

ZeClinics

3rd Vice-President

Javier Terriente

CSO at Zeclinics

3P Biopharmaceuticals

Member of the Board

Dámaso Molero

General Director at 3P Biopharmaceuticals since 2007, Dámaso Molero has extensive experience in pharmaceutical production, with 10 years as plant director at Shionogi.

AbbVie

Member of the Board

Antonio Bañares

Market Access & Government Affairs Director at AbbVie since 2013. He was previously Director of Health Management and Institutional Relations at Abbott Laboratories and General Director of the company’s foundation.

Ability Pharmaceuticals

Member of the Board

Carles Domenech

CEO and Vice-president of Business Development and Licensing at AbilityPharma since 2009. In parallel, he works as a consultant for biotech projects at investment firm Kieretsu Forum Spain.

ADL BIOPHARMA

Vocal

Ignacio Urbelz

Ignacio Urbelz is CEO of the company.

Algaenergy

Member of the Board

Augusto Rodríguez Villa

President and CEO of AlgaEnergy, a company working to create products from microalgae. He leads R&D projects in microalgae biotechnology.

Amadix

Member of the Board

Rocío Arroyo

CEO at Advanced Maker Discovery

Amgen

Vocal

Fina Lladós

General Manager of biotechnology firm Amgen for Spain and Portugal since September 2017 and a senior executive at the company since 2009.

Atrys Health

Member of the Board

Santiago de Torres

Executive Chairman of the Board at AtrysHealth. Torres, a physician specialising in Clinical Pharmacology, is also on the board of various social organisations.

Bayer Hispania S.L

Member of the Board

Richard Borreani

Director of Agricultural Policies and Institutional Relations at Bayer Crop Science Iberia, the agro division of the multinational, which is the third largest company in the world in products for agriculture.